Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China SXT Pharmaceuticals (SXTC) Goodwill & Intangibles: 2018-2025

Historic Goodwill & Intangibles for China SXT Pharmaceuticals (SXTC) over the last 8 years, with Mar 2025 value amounting to $11,808.

  • China SXT Pharmaceuticals' Goodwill & Intangibles fell 46.33% to $8,532 in Q3 2025 from the same period last year, while for Sep 2025 it was $8,532, marking a year-over-year decrease of 46.33%. This contributed to the annual value of $11,808 for FY2025, which is 38.18% down from last year.
  • As of FY2025, China SXT Pharmaceuticals' Goodwill & Intangibles stood at $11,808, which was down 38.18% from $19,101 recorded in FY2024.
  • In the past 5 years, China SXT Pharmaceuticals' Goodwill & Intangibles ranged from a high of $45,800 in FY2021 and a low of $11,808 during FY2025.
  • In the last 3 years, China SXT Pharmaceuticals' Goodwill & Intangibles had a median value of $19,101 in 2024 and averaged $19,592.
  • Data for China SXT Pharmaceuticals' Goodwill & Intangibles shows a maximum YoY slumped of 38.18% (in 2025) over the last 5 years.
  • Over the past 5 years, China SXT Pharmaceuticals' Goodwill & Intangibles (Yearly) stood at $45,800 in 2021, then dropped by 15.37% to $38,762 in 2022, then fell by 28.10% to $27,868 in 2023, then slumped by 31.46% to $19,101 in 2024, then tumbled by 38.18% to $11,808 in 2025.